Zhong Lin Selected Research

nedaplatin

4/2019	Phase II Study of a Bi-Weekly Chemotherapy Regimen of Combined Liposomal Paclitaxel and Nedaplatin for the Treatment of Advanced Squamous Cell Lung Cancer.
2/2017	Multi-institutional prospective study of nedaplatin plus S-1 chemotherapy in recurrent and metastatic nasopharyngeal carcinoma patients after failure of platinum-containing regimens.
1/2017	Efficacy and safety of pemetrexed and nedaplatin followed by pemetrexed maintenance therapy in advanced lung adenocarcinoma.
3/2016	Phase I trial of nedaplatin chemotherapy concurrent with radiotherapy for untreated locoregionally advanced nasopharyngeal carcinoma.
1/2015	Phase II trial of docetaxel combined with nedaplatin for patients with recurrent and metastatic nasopharyngeal carcinoma.
8/2013	Multicenter phase II study of capecitabine combined with nedaplatin for recurrent and metastatic nasopharyngeal carcinoma patients after failure of cisplatin-based chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhong Lin Research Topics

Disease

14	Neoplasms (Cancer) 10/2021 - 12/2003
10	Nasopharyngeal Carcinoma 08/2018 - 12/2003
8	Myopia 01/2022 - 05/2013
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2022 - 01/2013
5	vitreous floaters 01/2020 - 09/2016
4	Refractive Errors (Refractive Error) 01/2017 - 05/2013
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2022 - 01/2020
3	Disease Progression 02/2022 - 05/2016
3	Lung Neoplasms (Lung Cancer) 10/2020 - 04/2019
3	Ocular Motility Disorders (Convergence Insufficiency) 01/2020 - 11/2013
3	Wounds and Injuries (Trauma) 01/2018 - 01/2017
3	Endophthalmitis (Ophthalmia) 01/2018 - 09/2016
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 12/2015
2	Spontaneous Abortion (Miscarriage) 08/2020 - 06/2019
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2020 - 01/2017
2	Carcinoma (Carcinomatosis) 01/2019 - 01/2016
2	Cataract (Cataracts) 01/2018 - 09/2015
2	Retinal Detachment (Retinal Detachments) 01/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 12/2003
2	Adenocarcinoma of Lung 09/2017 - 01/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2014 - 12/2003
1	Thyroid Diseases (Thyroid Disease) 01/2022
1	Sleep Wake Disorders 01/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Diarrhea 01/2022
1	Exanthema (Rash) 01/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Proteinuria 01/2022
1	Dehydration (Water Stress) 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Epiretinal Membrane (Epiretinal Membranes) 01/2021
1	Glaucoma 01/2021
1	Burns 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021
1	COVID-19 11/2020
1	Nausea 03/2020
1	Vomiting 03/2020
1	Epstein-Barr Virus Infections 01/2020
1	Margins of Excision 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Insulin Resistance 06/2019

Drug/Important Bio-Agent (IBA)

7	Mydriatics (Cycloplegics)IBA 01/2022 - 05/2013
6	nedaplatinIBA 04/2019 - 08/2013
4	Pharmaceutical PreparationsIBA 01/2022 - 04/2018
4	PlatinumIBA 04/2019 - 01/2014
2	Immune Checkpoint InhibitorsIBA 02/2022 - 09/2017
2	Insulin (Novolin)FDA Link 01/2022 - 06/2019
2	Pemetrexed (MTA)FDA Link 10/2020 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 03/2020 - 08/2013
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 06/2019 - 04/2019
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2019 - 04/2018
2	Biological ProductsIBA 01/2019 - 03/2015
2	Lapatinib (GW572016)FDA Link 10/2016 - 01/2016
2	Codon (Codons)IBA 02/2016 - 09/2015
2	Small Interfering RNA (siRNA)IBA 03/2015 - 02/2014
1	EndostatinsIBA 02/2022
1	NivolumabIBA 02/2022
1	Long Noncoding RNAIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	Estazolam (ProSom)FDA LinkGeneric 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	aumolertinibIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	B7-H1 AntigenIBA 10/2021
1	CDX2 Transcription FactorIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 10/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2021
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	CreatinineIBA 01/2021
1	SoilIBA 01/2021
1	Vancomycin FDA LinkGeneric 01/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2020
1	Retinaldehyde (Retinal)IBA 07/2020
1	Aprepitant (Emend)FDA Link 03/2020
1	fosaprepitant FDA Link 03/2020
1	AntiemeticsIBA 03/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	LipidsIBA 06/2019
1	Glucose (Dextrose)FDA LinkGeneric 06/2019
1	HomocysteineIBA 06/2019

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 03/2020 - 12/2003
10	Vitrectomy 01/2021 - 09/2016
7	Therapeutics 01/2022 - 02/2014
3	Acupuncture Points (Acupuncture Point) 01/2020 - 11/2013
3	Radiotherapy 01/2020 - 11/2011
2	Chemoradiotherapy 03/2022 - 01/2020
2	Hysterectomy 03/2022 - 01/2021
2	Laparotomy 01/2021 - 12/2015
2	Anesthesia 07/2018 - 01/2017
2	Surgical Instruments (Clip) 07/2018 - 01/2018
2	Sutures (Suture) 01/2018 - 01/2018
2	Phacoemulsification 01/2018 - 09/2015
1	Immunotherapy 01/2022
1	Continuous Renal Replacement Therapy 01/2021
1	Catheters 11/2020